Non-syndromic anorectal malformation with rectourethral fistula, bulbar type

Summary

Non-syndromic anorectal malformation with rectourethral fistula, bulbar type (MONDO:0035782) is a disease. A subtype of anorectal malformation — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	non-syndromic anorectal malformation with rectourethral fistula, bulbar type
Mondo ID	MONDO:0035782
Orphanet	600966
UMLS	C5680243
MedGen	1843309
GARD	0022422
Is cancer (heuristic)	no

Also known as: Non-syndromic anorectal malformation with rectobulbar fistula · Non-syndromic ARM with rectobulbar fistula · Non-syndromic ARM with rectourethral fistula, bulbar type

Disease family

This is a subtype of anorectal malformation. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by developmental or physiological process › disorder of development or morphogenesis › anorectal malformation › non-syndromic anorectal malformation with rectourethral fistula, bulbar type

Related subtypes (4): hereditary anorectal anomalies, rectal duplication, non-syndromic anorectal malformation with rectourethral fistula, prostatic type, isolated anal canal duplication

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.